Fortis Healthcare Ltd. NSE: FORTIS | BSE: 532843

Download real time

932.75 -11.85 (-1.25%)

63.07% Gain from 52W Low

1.6M

NSE+BSE Volume

NSE 26 Sep, 2025 3:31 PM (IST)

Fortis Healthcare Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Fortis Healthcare Ltd. from all sources in a single place.

Fortis Healthcare Ltd.

26 Sep 2025

932.75

-1.25%

SAST

Fortis Healthcare Ltd - 532843 - Closure of Trading Window

BSE India

The relevant disclosure is attached.

Fortis Healthcare Ltd.

17 Sep 2025

932.75

-1.25%

Company Update

Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find attached the details of Investor Meetings with the Management Team of Fortis Healthcare Limited (''FHL''),

Fortis Healthcare Ltd.

17 Sep 2025

932.75

-1.25%

Company Update

Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find attached the details of Investor Meetings with the Management Team of Fortis Healthcare Limited ('FHL'),

Fortis Healthcare Ltd.

11 Sep 2025

932.75

-1.25%

Company Update

Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Publication of Special Window for re-lodgement of transfer requests of physical shares.

Fortis Healthcare Ltd.

09 Sep 2025

932.75

-1.25%

Company Update

Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Change in composition of Board pursuant to Appointment of Dr. Keith and resignation of Mr. Tomo Nagahiro effective from September 09, 2025 (close of business hours)

Fortis Healthcare Ltd.

08 Sep 2025

932.75

-1.25%

Company Update

Fortis Healthcare Ltd - 532843 - Status Of Re-Lodgement Of Transfer Requests Of Physical Shares For …

BSE India

The relevant disclosure is attached

Fortis Healthcare Ltd.

05 Sep 2025

932.75

-1.25%

Punjab CM Bhagwant Mann hospitalised at Fortis Hospital in Mohali

Business Standard

Punjab Chief Minister Bhagwant Mann was hospitalised on Friday evening after his health condition did not improve, party sources said. Mann (51) was suffering from viral fever and some digestion-related issues for the past two days. He was taken to Fortis Hospital in Mohali after his condition did not improve by evening. A team of doctors is examining him at the hospital. Following news of his illness, Aam Aadmi Party (AAP) national convener Arvind Kejriwal visited Mann on Thursday to check on his health at his official residence. Kejriwal arrived in Punjab on Wednesday evening to assess the flood situation and was originally scheduled to visit the affected areas alongside the chief minister. However, in Mann's absence, Kejriwal proceeded to visit the flood-hit areas in Sultanpur Lodhi in Kapurthala district. A year ago, too, Mann, who was diagnosed with a bacterial infection, had been admitted to Fortis Mohali for a few days. Meanwhile, earlier in the day, the meeting of the Pu

Number of FII/FPI investors increased from 452 to 512 in Jun 2025 qtr.

Fortis Healthcare Ltd.

05 Sep 2025

932.75

-1.25%

Company Update

Fortis Healthcare Ltd - 532843 - Execution Of Tripartite Agreement Among Uttar Pradesh Industrial Development Authority …

BSE India

The Relevant Disclosure with respect to Update on September 1, 2025 on Execution of Sub-Lease Agreement with R.R. Lifesciences Pvt. Ltd. is attached.

Fortis Healthcare Ltd.

01 Sep 2025

932.75

-1.25%

Company Update

Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

The relevant disclosure is attached.

Fortis Healthcare Ltd.

01 Sep 2025

932.75

-1.25%

Company Update

Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Disclosure with respect to Press Release "Fortis Healthcare expands NCR Presence" is attached.

Is Fortis Healthcare Ltd. worth buying?

327 Votes:

Buy 77.68%

Sell 11.01%

Hold 11.31%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >